ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ARS PHARMACEUTICALS INC
5.72
+0.3700
6.92%
盤後：
5.72
0.0000
0.00%
19:30 EDT
成交量：
171.58萬
成交額：
963.18萬
市值：
5.69億
市盈率：
-2.63
高：
5.76
開：
5.40
低：
5.39
收：
5.35
52周最高：
14.00
52周最低：
4.91
股本：
9,944.73萬
流通股本：
4,803.45萬
量比：
1.01
換手率：
3.57%
股息：
- -
股息率：
- -
每股收益(TTM):
-2.1757
每股收益(LYR):
-1.7400
淨資產收益率：
-210.35%
總資產收益率：
-48.02%
市淨率：
45.46
市盈率(LYR):
-3.29
資料載入中...
總覽
公司
新聞資訊
公告
新聞稿：ARS Pharmaceuticals宣佈首席執行官繼任計劃
投资观察
·
07/08
美股動態——Bumble、Tempus AI、TD Synnex
路透中文
·
06/26
ARS Pharma股價暴跌，因其過敏性鼻噴霧劑面臨醫保報銷障礙
路透中文
·
06/25
ARS Pharmaceuticals Inc：2026年現金運營總開支（不含銷售成本）下調至2.48億美元
美股速递
·
06/25
ARS Pharmaceuticals Inc重申Neffy基礎業務支持2027年實現現金流盈虧平衡
美股速递
·
06/25
德魯·布里斯攜手ARS製藥，提升嚴重過敏患者的生活質量意識
美股速递
·
06/04
市場快訊——美股行情動態-埃克森美孚、英特爾、英偉達
路透中文
·
05/16
市場快訊——美股行情-Cerebras、Papa John's、航空股
路透中文
·
05/15
熱門話題-ARS製藥公司股價上漲，因其第一季度營收超出預期
路透中文
·
05/15
ARS Pharmaceuticals：預計多數州級醫療補助計劃將在2027年初前將Neffy納入其無限制藥品目錄
美股速递
·
05/15
ARS製藥公司：CVS Caremark提案進入最終審批階段，預計6月初發布明確更新
美股速递
·
05/15
ARS Pharmaceuticals任命行業資深人士Donn Casale為總裁，強化領導團隊實力
美股速递
·
05/13
BUZZ-加拿大批准無針抗過敏噴霧後，ARS 製藥公司股價上漲
路透中文
·
04/15
ARS Pharmaceuticals Inc預計夏季前在加拿大提交Neffy 1毫克用於15-30公斤兒童的審批申請
美股速递
·
04/15
Neffy®（腎上腺素鼻噴霧劑）獲加拿大批准，成為首個且唯一用於過敏反應（過敏性休克）的無針急救療法
美股速递
·
04/15
ARS Pharmaceuticals Inc：Northland Capital 首次覆蓋給予「跑贏大盤」評級，目標價25美元
美股速递
·
04/09
ARS Pharmaceuticals獲FDA批准移除Neffy® 1毫克（腎上腺素鼻噴霧劑）標籤年齡限制
美股速递
·
03/27
Ars Pharmaceuticals, Inc.2025財年實現淨利潤-1.71億美元，按年減少2237.50%
市场透视
·
03/10
Ars Pharmaceuticals, Inc.盤中異動 早盤快速跳水5.41%
市场透视
·
03/09
ARS Pharmaceuticals公布2025年第四季度及全年財報，並更新Neffy®（腎上腺素鼻噴霧劑）商業化進展
美股速递
·
03/09
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/SPRY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":5.72,"timestamp":1787688000000,"preClose":5.35,"halted":0,"volume":1715834,"hourTrading":{"tag":"盘后","latestPrice":5.72,"preClose":5.72,"latestTime":"19:30 EDT","volume":217681,"amount":1245137.08,"timestamp":1787700602255,"change":0,"changeRate":0,"amplitude":0.001748},"delay":0,"changeRate":0.06915887850467292,"floatShares":48034500,"shares":99447343,"eps":-2.175701,"marketStatus":"已收盤","change":0.37,"latestTime":"08-25 16:00:00 EDT","open":5.4,"high":5.76,"low":5.39,"amount":9631824.550329601,"amplitude":0.069159,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.175701,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":5.35,"preHourTrading":{"tag":"盘前","latestPrice":5.35,"preClose":5.35,"latestTime":"07:33 EDT","volume":208,"amount":1112.449936,"timestamp":1787657624084,"change":0,"changeRate":0,"amplitude":0.046729},"postHourTrading":{"tag":"盘后","latestPrice":5.72,"preClose":5.72,"latestTime":"19:30 EDT","volume":217681,"amount":1245137.08,"timestamp":1787700602255,"change":0,"changeRate":0,"amplitude":0.001748},"volumeRatio":1.012074,"impliedVol":0.5993,"impliedVolPercentile":0.0956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":48034500,"roa":"-48.02%","roe":"-210.35%","lyrEps":-1.74,"volumeRatio":1.012074,"shares":99447343,"dividePrice":0,"high":5.76,"amplitude":0.069159,"preClose":5.35,"low":5.39,"week52Low":4.9102,"pbRate":"45.46","psRate":"4.86","week52High":13.9987,"institutionHeld":0,"latestPrice":5.72,"eps":-2.175701,"divideRate":0,"volume":1715834,"delay":0,"ttmEps":-2.175701,"open":5.4,"prevYearClose":11.65,"prevWeekClose":5.505,"prevMonthClose":5.13,"prevQuarterClose":8.01,"fiveDayClose":6.3,"twentyDayClose":5.67,"sixtyDayClose":9.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"SPRY","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-15","symbol":"SPRY","fiscalQuarterEnding":"2026/03","expectedEps":-0.53,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.61},{"market":"US","date":"2026-03-09","symbol":"SPRY","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-11-10","symbol":"SPRY","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"SPRY","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1775966400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2026-08-24","current":-2.592268,"percent":0.957377,"low":-115.157754,"twenty":-28.534516,"median":-16.610627,"eighty":-7.363398,"high":184.020638,"avg":-15.291106,"sd":44.45059,"marketCap":547457623},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013},{"date":"2025-08-01","current":-110.953084,"twenty":-30.649879,"median":-18.318793,"eighty":-12.05734,"marketCap":1736415758},{"date":"2025-08-08","current":-110.764815,"twenty":-30.849578,"median":-18.491503,"eighty":-12.236498,"marketCap":1733469351},{"date":"2025-08-15","current":-29.781475,"twenty":-31.056082,"median":-18.779127,"eighty":-12.27233,"marketCap":1430017096},{"date":"2025-09-05","current":-22.001657,"twenty":-31.011769,"median":-19.029654,"eighty":-12.286663,"marketCap":1056453542},{"date":"2025-09-12","current":-20.890254,"twenty":-30.966274,"median":-19.71207,"eighty":-12.321272,"marketCap":1003087320},{"date":"2025-09-19","current":-20.43746,"twenty":-30.871196,"median":-20.12152,"eighty":-12.329028,"marketCap":981345526},{"date":"2025-09-26","current":-19.63478,"twenty":-30.797693,"median":-20.134768,"eighty":-12.355333,"marketCap":942803254},{"date":"2025-10-03","current":-21.157814,"twenty":-30.698248,"median":-20.149319,"eighty":-12.390575,"marketCap":1015934744},{"date":"2025-10-10","current":-23.833413,"twenty":-30.67,"median":-20.178749,"eighty":-12.426406,"marketCap":1144408982},{"date":"2025-10-17","current":-20.807928,"twenty":-30.653572,"median":-20.2775,"eighty":-12.47657,"marketCap":999134267},{"date":"2025-10-24","current":-19.861177,"twenty":-30.649879,"median":-20.299599,"eighty":-12.515985,"marketCap":953674152},{"date":"2025-10-31","current":-17.74128,"twenty":-30.620337,"median":-20.187599,"eighty":-12.551817,"marketCap":851883024},{"date":"2025-11-07","current":-16.866565,"twenty":-30.612951,"median":-20.149319,"eighty":-12.587649,"marketCap":809881831},{"date":"2025-11-14","current":-10.386267,"twenty":-30.612951,"median":-20.12152,"eighty":-12.426406,"marketCap":831316818},{"date":"2025-11-21","current":-8.311484,"twenty":-30.553867,"median":-19.933213,"eighty":-12.321272,"marketCap":665251152},{"date":"2025-11-28","current":-11.781806,"twenty":-30.491905,"median":-19.75827,"eighty":-12.164835,"marketCap":943015748},{"date":"2025-12-05","current":-12.312852,"twenty":-30.408561,"median":-19.63478,"eighty":-11.836649,"marketCap":985520651},{"date":"2025-12-12","current":-13.856589,"twenty":-30.373971,"median":-19.314339,"eighty":-11.916185,"marketCap":1109081415},{"date":"2025-12-19","current":-12.127603,"twenty":-30.309116,"median":-19.029654,"eighty":-12.021508,"marketCap":970693360},{"date":"2025-12-26","current":-14.177687,"twenty":-30.256997,"median":-18.779127,"eighty":-12.085445,"marketCap":1134782054},{"date":"2026-01-02","current":-14.387635,"twenty":-30.230821,"median":-18.672648,"eighty":-12.149382,"marketCap":1151586318},{"date":"2026-01-09","current":-13.523142,"twenty":-30.165419,"median":-18.491503,"eighty":-12.241889,"marketCap":1082392290},{"date":"2026-01-16","current":-13.696041,"twenty":-30.101841,"median":-18.441052,"eighty":-12.263452,"marketCap":1096231095},{"date":"2026-01-23","current":-13.053846,"twenty":-30.071312,"median":-18.318793,"eighty":-12.263452,"marketCap":1044829818},{"date":"2026-01-30","current":-12.621599,"twenty":-30.016829,"median":-18.156476,"eighty":-12.27233,"marketCap":1010232804},{"date":"2026-02-06","current":-11.942355,"twenty":-30.006457,"median":-18.060207,"eighty":-12.27233,"marketCap":955866068},{"date":"2026-02-13","current":-10.880263,"twenty":-29.970507,"median":-17.96922,"eighty":-12.251102,"marketCap":870856262},{"date":"2026-02-20","current":-11.658307,"twenty":-29.864079,"median":-17.933958,"eighty":-12.08391,"marketCap":933130887},{"date":"2026-02-27","current":-11.534808,"twenty":-29.792674,"median":-17.810106,"eighty":-11.837735,"marketCap":923246026},{"date":"2026-03-06","current":-11.26311,"twenty":-29.719333,"median":-17.772592,"eighty":-11.771926,"marketCap":901499332},{"date":"2026-03-13","current":-4.776529,"twenty":-29.651913,"median":-17.742813,"eighty":-11.650793,"marketCap":818209809},{"date":"2026-03-20","current":-4.782325,"twenty":-29.587058,"median":-17.742047,"eighty":-11.574328,"marketCap":819202782},{"date":"2026-03-27","current":-4.962025,"twenty":-29.539497,"median":-17.728408,"eighty":-11.403899,"marketCap":849984947},{"date":"2026-04-02","current":-4.701171,"twenty":-29.515414,"median":-17.719962,"eighty":-11.300637,"marketCap":805301159},{"date":"2026-04-10","current":-4.793919,"twenty":-29.472136,"median":-17.701176,"eighty":-11.16712,"marketCap":821188728},{"date":"2026-04-17","current":-4.741748,"twenty":-29.342914,"median":-17.679674,"eighty":-11.054765,"marketCap":812251971},{"date":"2026-04-24","current":-4.811309,"twenty":-29.218388,"median":-17.626125,"eighty":-10.944483,"marketCap":824167648},{"date":"2026-05-01","current":-4.788122,"twenty":-29.176877,"median":-17.592246,"eighty":-10.860503,"marketCap":820195755},{"date":"2026-05-08","current":-5.217082,"twenty":-29.123341,"median":-17.508842,"eighty":-10.149584,"marketCap":893675763},{"date":"2026-05-15","current":-4.602781,"twenty":-29.051193,"median":-17.430851,"eighty":-10.056766,"marketCap":788447224},{"date":"2026-05-22","current":-4.128106,"twenty":-29.025066,"median":-17.419754,"eighty":-9.920468,"marketCap":817265846},{"date":"2026-05-29","current":-4.714969,"twenty":-29.002547,"median":-17.374861,"eighty":-9.799739,"marketCap":933450662},{"date":"2026-06-05","current":-4.549443,"twenty":-28.908237,"median":-17.313866,"eighty":-9.477287,"marketCap":900680586},{"date":"2026-06-12","current":-4.810271,"twenty":-28.815444,"median":-17.262136,"eighty":-9.284127,"marketCap":952318282},{"date":"2026-06-18","current":-4.965765,"twenty":-28.81066,"median":-17.21396,"eighty":-9.20624,"marketCap":983102293},{"date":"2026-06-26","current":-4.022771,"twenty":-28.794286,"median":-17.19688,"eighty":-8.798113,"marketCap":796412161},{"date":"2026-07-02","current":-3.982644,"twenty":-28.757432,"median":-17.177383,"eighty":-8.749905,"marketCap":788467900},{"date":"2026-07-10","current":-3.952548,"twenty":-28.752585,"median":-17.10772,"eighty":-8.311484,"marketCap":782509704},{"date":"2026-07-17","current":-3.741879,"twenty":-28.717849,"median":-17.021402,"eighty":-8.1314,"marketCap":740802334},{"date":"2026-07-24","current":-3.009555,"twenty":-28.627161,"median":-16.884919,"eighty":-8.115823,"marketCap":595819572},{"date":"2026-07-31","current":-2.823965,"twenty":-28.604711,"median":-16.872443,"eighty":-8.050398,"marketCap":559077365},{"date":"2026-08-07","current":-2.783838,"twenty":-28.551598,"median":-16.842675,"eighty":-7.822968,"marketCap":551133104},{"date":"2026-08-14","current":-3.064153,"twenty":-28.537065,"median":-16.689461,"eighty":-7.495842,"marketCap":606628792},{"date":"2026-08-21","current":-2.541208,"twenty":-28.534893,"median":-16.6288,"eighty":-7.404552,"marketCap":547457623},{"date":"2026-08-24","current":-2.541208,"twenty":-28.534516,"median":-16.610627,"eighty":-7.363398,"marketCap":547457623}],"updateTime":1787685452459},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1121444252","title":"新聞稿：ARS Pharmaceuticals宣佈首席執行官繼任計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1121444252","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121444252?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 04:31","pubTimestamp":1783456303,"startTime":"0","endTime":"0","summary":"致力于赋能高危患者及其护理人员、以更好地预防可能导致过敏性休克的过敏反应的生物制药公司ARS Pharmaceuticals, Inc.今日宣布首席执行官继任计划。联合创始人兼首席执行官理查德·洛温塔尔自2026年7月6日起，将不再担任公司雇员及高管职务。董事会已任命现任总裁唐恩·卡萨莱为首席执行官兼董事，自2026年7月7日起生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139","BK4232","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646780060","title":"美股動態——Bumble、Tempus AI、TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646780060","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646780060?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 01:56","pubTimestamp":1782410212,"startTime":"0","endTime":"0","summary":".N美国东部时间13:31，道琼斯工业平均指数.DJI上涨0.31%，报52,008.43点。标普500指数.SPX上涨0.02%，报7,359.41点；纳斯达克综合指数.IXIC下跌0.43%，报25,365.84点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X1V3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MU","TSHA","CDNL","CRWG","MOGU","PLTW","GRAL","CRWV","AAPY","WDC","DELL","PSTV","PLTD","PSNY","SNDK","ELV","AKAM","KYMR","DRI","PRFX","NNOX","TECH","WEN","BX","CSIQ","DLTR","INMB","MEI","ILLR","AZI","BMBL","MRK","DPC","AYI","PLTR","IBM","NUVB","PLTA","TEM","VANI","STX","LLY","SPRY","QCOM","HTZ","MKC","SNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646805257","title":"ARS Pharma股價暴跌，因其過敏性鼻噴霧劑面臨醫保報銷障礙","url":"https://stock-news.laohu8.com/highlight/detail?id=2646805257","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646805257?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 21:40","pubTimestamp":1782394840,"startTime":"0","endTime":"0","summary":"BUZZ-ARS Pharma股价暴跌，因其过敏性鼻喷雾剂面临医保报销障碍6月25日-** ARS Pharmaceuticals（SPRY.O）股价下跌26%至7.79美元，结束了连续三天的上涨势头** ARS制药公司周三晚间 (link) 表示，其过敏喷雾剂“Neffy”在7月的最新审批周期中未获得任何新的保险报销批准** “Neffy”是一种用于紧急治疗严重过敏反应的肾上腺素鼻喷雾剂，目前已","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4T42X1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU0320765489.SGD","LU2433249047.HKD","BK4581","IE00BSNM7G36.USD","LU0072461881.USD","IE00B19Z3B42.SGD","BK4585","BK4588","LU0162691827.USD","LU2125909593.SGD","IE0002270589.USD","LU1983299246.USD","LU1923622614.USD","CVS","BK4504","LU2125909247.SGD","LU0006061336.USD","BK4139","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0070302665.USD","BK4550","LU1571399168.USD","LU1699723380.USD","LU0061475181.USD","LU1059921491.USD","SPRY","LU0211331839.USD","LU0432979614.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190087573","title":"ARS Pharmaceuticals Inc：2026年現金運營總開支（不含銷售成本）下調至2.48億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190087573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190087573?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 04:16","pubTimestamp":1782332174,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc 已将其2026年现金运营总开支（不含销货成本）的预期下调至2.48亿美元。这一调整反映了公司对运营效率的持续优化与成本控制措施的强化。通过审慎的财务规划，公司旨在更有效地配置资源，为未来的研发投入和业务拓展创造更有利的财务空间。此举有望提升公司的整体财务健康度与市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116281092","title":"ARS Pharmaceuticals Inc重申Neffy基礎業務支持2027年實現現金流盈虧平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=1116281092","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116281092?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 04:15","pubTimestamp":1782332113,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc重申，其核心产品Neffy的基础业务，为公司规划了一条在2027年实现现金流盈亏平衡的可行路径。这一表态强化了公司对未来财务表现的信心与具体预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143413101","title":"德魯·布里斯攜手ARS製藥，提升嚴重過敏患者的生活質量意識","url":"https://stock-news.laohu8.com/highlight/detail?id=1143413101","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143413101?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 20:04","pubTimestamp":1780574686,"startTime":"0","endTime":"0","summary":"前NFL传奇四分卫德鲁·布里斯宣布与生物制药公司ARS Pharmaceuticals合作，共同发起一项旨在提高公众对严重过敏反应认知的倡议。该合作计划将聚焦于那些与严重过敏共存的个体，致力于推广相关的疾病教育，并探讨创新治疗方案如何改善患者的日常生活。布里斯以其卓越的体育生涯闻名，此次跨界合作凸显了他对公共卫生领域的关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635504039","title":"市場快訊——美股行情動態-埃克森美孚、英特爾、英偉達","url":"https://stock-news.laohu8.com/highlight/detail?id=2635504039","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635504039?lang=zh_tw&edition=fundamental","pubTime":"2026-05-16 00:37","pubTimestamp":1778863058,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数 .DJI 下跌0.87%，报49,626.37点。标普500指数 .SPX 下跌0.89%，报7,434.39点；纳斯达克综合指数 .IXIC 下跌1.15%，报26,328.89点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","GLOB","ALK","CDE","MSFY","DXCM","NEMG","SPRY","UAL","ELPW","YSS","SSTK","GEMI","LUV","AMD","AU","INTC","NVDA","ORRF","F","AMAT","AMYY","DAL","ARM","CVX","CCNE","UNTY","GETY","NOW","PSX","VLO","WOK","BW","PZZA","XOM","CBRS","LNZA","FIG","EBC","MSFT","HCWB","HUBC","NEM","FIGG","HL","RXO","FDS","PIII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081300","title":"市場快訊——美股行情-Cerebras、Papa John's、航空股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081300","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081300?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:52","pubTimestamp":1778845964,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S13P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4008","LU0353189680.USD","LU2433249047.HKD","LUV","LU1023059493.AUD","LU2065731478.USD","LU1430597077.USD","LU0345780281.USD","BK4122","BK4077","NEMG","IE00B19Z3581.USD","LU0345781412.USD","BK4504","LU2462611646.USD","ALK","LU1883866441.USD","IE0002270589.USD","LU0368265764.SGD","IE00BFMHRM44.USD","LU1223082196.USD","LU2210150020.SGD","LU0055631609.USD","CBRS","BK4534","LU2125909593.SGD","LU0052756011.USD","BK4082","LU0170899867.USD","BK4532","LU0788108826.HKD","SG9999001143.SGD","LU0724618789.USD","LU2087625088.SGD","LU0456854461.SGD","BK4585","LU1323610961.USD","BK4209","LU0345780521.USD","LU0612318971.USD","LU1223083913.SGD","LU0266512473.USD","GEMG","LU2095319765.USD","FIGG","LU0498741114.HKD","LU0640476718.USD","LU2125909247.SGD","LU0128525689.USD","BK4551","LU0654597011.USD","PZZA","IE00BMPRXR70.SGD","LU0310800965.SGD","BK4533","NWMX","LU0300736062.USD","SSTK","LU1102505929.USD","DXCM","AU","IE00B19Z3B42.SGD","DAL","LU0266013472.USD","LU2211815571.USD","NEM","LU1223082519.USD","LU0143863198.USD","FIG","BK4570","LU0278409577.USD","LU1267930227.SGD","BK4112","BK4139","LU0075056555.USD","LU0630314457.HKD","BK4588","LU0143863784.USD","LU1102505762.USD","LU0612318385.USD","LU0266512127.USD","LU0354030438.USD","LU0496367417.USD","GETY","BK4017","BK4023","BK4548","LU0330918003.SGD","BK4500","BK4211","UAL","LU1923622614.USD","GEMI","BK4522","LU1280957306.USD","LU0788109121.HKD","IE00BMPRXN33.USD","LU0300736492.USD","SPRY","LU0353189763.USD","LU0303823156.USD","LU1868837565.USD","LU2210149790.SGD","LU2498475776.HKD","ORRF","LU1868838027.USD","LU0354030511.USD","LU0498741890.SGD","LU0303821028.USD","LU0345780950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635208599","title":"熱門話題-ARS製藥公司股價上漲，因其第一季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2635208599","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635208599?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 18:48","pubTimestamp":1778842091,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187836714","title":"ARS Pharmaceuticals：預計多數州級醫療補助計劃將在2027年初前將Neffy納入其無限制藥品目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1187836714","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187836714?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 18:06","pubTimestamp":1778839603,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals 预计，到2027年初，大多数州级医疗补助计划将把其药物Neffy纳入其无限制的医疗补助药品目录中。这一进展有望扩大该药物的覆盖范围和患者可及性，对公司未来市场拓展具有积极意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165973837","title":"ARS製藥公司：CVS Caremark提案進入最終審批階段，預計6月初發布明確更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1165973837","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165973837?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 18:04","pubTimestamp":1778839479,"startTime":"0","endTime":"0","summary":"ARS制药公司宣布，其与CVS Caremark的提案已进入审批流程的最后阶段。公司预计将在6月初提供一份明确的更新信息，以披露该提案的最终结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129690559","title":"ARS Pharmaceuticals任命行業資深人士Donn Casale為總裁，強化領導團隊實力","url":"https://stock-news.laohu8.com/highlight/detail?id=1129690559","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129690559?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 20:03","pubTimestamp":1778673829,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals宣布任命行业资深人士唐·卡萨莱（Donn Casale）为公司总裁，此举旨在进一步强化其领导团队。\n卡萨莱在生物制药领域拥有丰富的管理经验，他的加入将为公司带来宝贵的行业洞见和战略领导力。此次人事任命体现了ARS Pharmaceuticals持续加强其管理层，以推动公司未来发展的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627283324","title":"BUZZ-加拿大批准無針抗過敏噴霧後，ARS 製藥公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283324","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627283324?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 18:16","pubTimestamp":1776248189,"startTime":"0","endTime":"0","summary":"BUZZ-加拿大批准无针抗过敏喷雾后，ARS 制药公司股价上涨4月15日 - ** ARS制药公司SPRY.O股价盘前上涨2%至8.30美元** 药物开发商称加拿大卫生部批准了neffy，一种用于成人和体重超过30公斤的儿童严重过敏反应的无针肾上腺素鼻喷雾剂。** 公司称，neffy 是传统肾上腺素自动注射器的替代品，一些患者因害怕针头而避免使用这种注射器。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4S40Y0SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158905047","title":"ARS Pharmaceuticals Inc預計夏季前在加拿大提交Neffy 1毫克用於15-30公斤兒童的審批申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1158905047","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158905047?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 18:09","pubTimestamp":1776247779,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc计划于夏季前向加拿大监管机构提交其Neffy 1毫克产品的审批申请，该产品适用于体重在15至30公斤之间的儿童群体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159278174","title":"Neffy®（腎上腺素鼻噴霧劑）獲加拿大批准，成為首個且唯一用於過敏反應（過敏性休克）的無針急救療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1159278174","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159278174?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 18:08","pubTimestamp":1776247693,"startTime":"0","endTime":"0","summary":"Neffy®（肾上腺素鼻喷雾剂）已在加拿大获得批准，成为该国首个且唯一用于治疗过敏反应（包括危及生命的过敏性休克）的无针急救疗法。这一批准标志着严重过敏反应应急管理领域的重大突破，为患者提供了一种无需注射的便捷替代方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161492576","title":"ARS Pharmaceuticals Inc：Northland Capital 首次覆蓋給予「跑贏大盤」評級，目標價25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161492576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161492576?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 19:47","pubTimestamp":1775735233,"startTime":"0","endTime":"0","summary":"Northland Capital 近日宣布对 ARS Pharmaceuticals Inc 启动研究覆盖，并给予“跑赢大盘”的积极评级。该机构同时设定了25美元的目标股价，显示出对公司未来增长潜力的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189355008","title":"ARS Pharmaceuticals獲FDA批准移除Neffy® 1毫克（腎上腺素鼻噴霧劑）標籤年齡限制","url":"https://stock-news.laohu8.com/highlight/detail?id=1189355008","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189355008?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 20:05","pubTimestamp":1774613127,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals公司宣布，其研发的Neffy 1毫克剂量肾上腺素鼻喷雾剂已获得美国食品药品监督管理局批准，将取消药品标签中的年龄使用限制。这一重要监管突破意味着该鼻喷雾剂未来可适用于更广泛的年龄群体，为不同年龄段患者提供更便捷的严重过敏反应应急治疗方案。移除年龄限制不仅拓宽了Neffy的适用人群，更凸显了ARS Pharmaceuticals在创新给药系统研发领域的技术实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618603224","title":"Ars Pharmaceuticals, Inc.2025財年實現淨利潤-1.71億美元，按年減少2237.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618603224?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 06:00","pubTimestamp":1773093635,"startTime":"0","endTime":"0","summary":"3月10日，Ars Pharmaceuticals, Inc.公布财报，公告显示公司2025财年净利润为-1.71亿美元，同比减少2237.50%；其中营业收入为84.28百万美元，同比减少5.46%，每股基本收益为-1.74美元。从资产负债表来看，Ars Pharmaceuticals, Inc.总负债2.13亿美元，其中短期债务588000.00美元，资产负债比为1.54，流动比率为0.08。机构评级：截至2026年3月10日，当前有4家机构对Ars Pharmaceuticals, Inc.目标价做出预测，其中目标均价为27.50美元，其中最低目标价为12.00美元，最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310060045a45c9176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310060045a45c9176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618603202","title":"Ars Pharmaceuticals, Inc.盤中異動 早盤快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618603202?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 22:06","pubTimestamp":1773065186,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时06分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.41%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Xenon制药、Relmada Therapeutics, Inc.、Atara Biotherapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、Moolec Science Sa、Atara Biotherapeutics, Inc.较为活跃，换手率分别为35.41%、19.04%、18.11%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Biohaven Ltd.、An2 Therapeutics, Inc.，振幅分别为33.71%、28.63%、27.37%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922062695461e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922062695461e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196337167","title":"ARS Pharmaceuticals公布2025年第四季度及全年財報，並更新Neffy®（腎上腺素鼻噴霧劑）商業化進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1196337167","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196337167?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 18:05","pubTimestamp":1773050705,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc（纳斯达克代码：SPRY）近日披露了2025年第四季度及全年的财务业绩，同时就旗下创新产品Neffy®（肾上腺素鼻喷雾剂）的商业化进程提供了最新动态。报告显示，公司在关键财务指标上达成预期目标，并为鼻喷雾剂的上市筹备工作制定了明确时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}